Roviello Franco, Roviello Giandomenico, Petrioli Roberto, Marrelli Daniele
Department of Medicine, Surgery and Neurosciences, Unit of General and Mini-Invasive Surgery, University of Siena, Policlinico "Le Scotte", Viale Bracci, 53100 Siena, Italy.
Medical Oncology Unit, University of Siena, Viale Bracci 11, 53100 Siena, Italy.
Crit Rev Oncol Hematol. 2015 Sep;95(3):297-305. doi: 10.1016/j.critrevonc.2015.03.007. Epub 2015 Apr 11.
Ovarian cancer (OC) is the sixth most common neoplasm in women. Hyperthermic intraperitoneal chemotherapy (HIPEC), a strategy combining maximal cytoreductive surgery with maximal regional chemotherapy, has been proposed to treat OC. At present, less randomized trials has determined HIPEC real impact on patients with OC. In this brief report, we reported results of selected studies of treatment with HIPEC for patients with OC. Future prospects are conclusively discussed.
卵巢癌（OC）是女性中第六大常见肿瘤。腹腔热灌注化疗（HIPEC）是一种将最大程度的肿瘤细胞减灭术与最大程度的区域化疗相结合的治疗策略，已被用于治疗卵巢癌。目前，较少有随机试验确定HIPEC对卵巢癌患者的实际影响。在本简要报告中，我们报告了针对卵巢癌患者采用HIPEC治疗的部分研究结果。并对未来前景进行了总结性讨论。
